Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard H Bailey

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|October 13, 2012
A phase III skin cancer chemoprevention study of DFMO: long-term follow-up of skin cancer events and toxicitySarah M Kreul, Tom Havighurst, KyungMann Kim, et al.
Cancer|October 24, 2006
Phase II study of daily oral perifosine in patients with advanced soft tissue sarcomaHoward H Bailey, Michelle R Mahoney, David S Ettinger, et al.
American Journal of Clinical Oncology|June 11, 2003
Gemcitabine, Paclitaxel, and piritrexim: a phase I studyGlenn Liu, Howard H Bailey, Rhoda Z Arzoomanian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2007
Phase I trial of weekly paclitaxel and BMS-214662 in patients with advanced solid tumorsHoward H Bailey, Dona B Alberti, James P Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
AIDS-related Kaposi's sarcoma of the gastrointestinal tractSteven Attia, Bruce J Dezube, Jose R Torrealba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2016
American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer PreventionHoward H Bailey, Linus T Chuang, Nefertiti C duPont, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 3, 2014
A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancerKari B Wisinski, Wendy M Ledesma, Jill Kolesar, et al.
Journal of Oncology Practice|May 2, 2013
Inpatient hospitalization of oncology patients: are we missing an opportunity for end-of-life care?Gabrielle B Rocque, Anne E Barnett, Lisa C Illig, et al.
Journal of Oncology Practice|December 12, 2019
Oncologic Implications of Chronic Hepatitis C Virus InfectionJessica P Hwang, Noelle K LoConte, John P Rice, et al.
American Journal of Clinical and Experimental Urology|October 22, 2016
Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D<sub>3</sub>) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomyDavid Jarrard, Badrinath Konety, Wei Huang, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Cancer Prevention Research (Philadelphia, Pa.)|October 13, 2012
A phase III skin cancer chemoprevention study of DFMO: long-term follow-up of skin cancer events and toxicitySarah M Kreul, Tom Havighurst, KyungMann Kim, et al.
Cancer|October 24, 2006
Phase II study of daily oral perifosine in patients with advanced soft tissue sarcomaHoward H Bailey, Michelle R Mahoney, David S Ettinger, et al.
American Journal of Clinical Oncology|June 11, 2003
Gemcitabine, Paclitaxel, and piritrexim: a phase I studyGlenn Liu, Howard H Bailey, Rhoda Z Arzoomanian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2007
Phase I trial of weekly paclitaxel and BMS-214662 in patients with advanced solid tumorsHoward H Bailey, Dona B Alberti, James P Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
AIDS-related Kaposi's sarcoma of the gastrointestinal tractSteven Attia, Bruce J Dezube, Jose R Torrealba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2016
American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer PreventionHoward H Bailey, Linus T Chuang, Nefertiti C duPont, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 3, 2014
A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancerKari B Wisinski, Wendy M Ledesma, Jill Kolesar, et al.
Journal of Oncology Practice|May 2, 2013
Inpatient hospitalization of oncology patients: are we missing an opportunity for end-of-life care?Gabrielle B Rocque, Anne E Barnett, Lisa C Illig, et al.
Journal of Oncology Practice|December 12, 2019
Oncologic Implications of Chronic Hepatitis C Virus InfectionJessica P Hwang, Noelle K LoConte, John P Rice, et al.
American Journal of Clinical and Experimental Urology|October 22, 2016
Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D<sub>3</sub>) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomyDavid Jarrard, Badrinath Konety, Wei Huang, et al.
Pageof 6